Abstract:Prostate cancer is a main health risk for males with a high incidence and mortality. The present study aimed to examine the effects of long non‑coding RNA (lncRNA) MIR4435‑2HG binding with ST8SIA1 on the proliferation, invasion and migration of prostate cancer cells via the activation of the FAK/AKT/β‑catenin signaling pathway. The expression of MIR4435‑2HG and ST8SIA1 in prostate cancer cell lines, and the transfection efficacy were analyzed by RT‑qPCR. The proliferation, clone formation ability, and the invasion and migration of transfected cells were detected by CCK‑8 assay, clone formation assay, Transwell assay and wound healing assay, respectively. Plasmids were injected subcutaneously into mice to construct a xenograft tumor model. The expression levels of proteins related to proliferation, apoptosis, invasion and migration, and the FAK/AKT/β‑catenin pathway were detected by western blot analysis. The results revealed that MIR4435‑2HG expression was increased in the prostate cancer cell lines and MIR4435‑2HG expression was the highest in the PC‑3 cells. Interference with MIR4435‑2HG inhibited the proliferation, clone formation ability, and the invasion and migration of PC‑3 cells, as well as tumor growth by suppressing the activation of the FAK/AKT/β‑catenin signaling pathway. MIR4435‑2HG was demonstrated to target ST8SIA1. ST8SIA1 expression was also increased in the prostate cancer cell lines and MIR4435‑2HG expression was the highest in the PC‑3 cells. Interference with ST8SIA1 inhibited the promoting effects of MIR4435‑2HG on the proliferation, invasion and migration of PC‑3 cells, as well as tumor growth by suppressing the activation of the FAK/AKT/β‑catenin signaling pathway. On the whole, the present study demonstrates that interference with MIR4435‑2HG, combined with ST8SIA1, inhibits the proliferation, invasion and migration of prostate cancer cells in vitro and in vivo by blocking the activation of the FAK/AKT/β‑catenin signaling pathway.

Long noncoding RNA MIR22HG is down-regulated in prostate cancer

Downregulation of Long Non-Coding RNA MR4435-2HG Suppresses Breast Cancer Progression Via the Wnt/β-catenin Signaling Pathway.

Mir-181a-5p Is Downregulated And Inhibits Proliferation And The Cell Cycle In Prostate Cancer

Downregulation of Mir-195 Promotes Prostate Cancer Progression by Targeting HMGA1.

Expression of lncRNA PCGEM1 and AR co-localization in prostate cancer and tis signiifcance

Prognostic Values of Long Non-Coding RNA MIR22HG for Patients with Hepatocellular Carcinoma after Hepatectomy.

The crucial role of LncRNA MIR210HG involved in the regulation of human cancer and other disease

Suppression of CX43 Expression by Mir-20A in the Progression of Human Prostate Cancer.

Long non‐coding RNA MIR31HG as a prognostic predictor for malignant cancers: A meta‐ and bioinformatics analysis

Emerging impact of the long noncoding RNA MIR22HG on proliferation and apoptosis in multiple human cancers

Expression of Lncrna MIR222HG Co-Transcribed from the Mir-221/222 Gene Promoter Facilitates the Development of Castration-Resistant Prostate Cancer

Downregulation of Mirna-205 Expression and Biological Mechanism in Prostate Cancer Tumorigenesis and Bone Metastasis.

Up-regulated Mir-29C Inhibits Cell Proliferation and Glycolysis by Inhibiting SLC2A3 Expression in Prostate Cancer

Knockdown of lncRNA MIR4435‑2HG and ST8SIA1 expression inhibits the proliferation, invasion and migration of prostate cancer cells in vitro and in vivo by blocking the activation of the FAK/AKT/β‑catenin signaling pathway

Downregulation of long non-coding RNA HCG11 predicts a poor prognosis in prostate cancer.

MIR22HG As A Tumor Suppressive lncRNA In HCC: A Comprehensive Analysis Integrating RT-qPCR, mRNA-Seq, And Microarrays.

Downregulation of Mir-199A-5p Promotes Prostate Adeno-Carcinoma Progression Through Loss of Its Inhibition of HIF-1α.

Mir-1231 is Downregulated in Prostate Cancer with Prognostic and Functional Implications

Diagnostic and Prognostic Values of Tissue Hsa-Mir-30c and Hsa-Mir-203 in Prostate Carcinoma

LncRNA HCG18 promotes prostate cancer progression by regulating miR-512-3p/HK-2 axis

Decreased long noncoding RNA MIR31HG is correlated with poor prognosis and contributes to cell proliferation in gastric cancer